Cerebrospinal-fluid τ protein and aspartate aminotransferase in Parkinson's disease

Lancet

Volumn 351, Issue 9109, 1998, Pages 1105-1106

  Jansen Steur, E ^b   Vermes, I ^a   De Vos, R A I ^b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 17444436464     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)79387-9     Document Type: Article

References (2)

1. 1 Riemenschneider M, Buch K, Schmolke M, Kurz A, Guder WG. Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase. Lancet 1997; 350: 784.
2. 2 Jendroska K, Lees A, Poewe W, Daniel SE. Amyloid β-peptide and dementia of Parkinson's disease. Movement Disorders 1996; 11: 647-53.